Lantern Pharma Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dallas, TX
SEC filing record 1 source field available
Fiscal year end
31 December
Lantern Pharma Inc. has filed 246 SEC EDGAR filings since 14 Jan 2019

SEC filing history

Showing 1-25 of 246 matching filings.

Per page
25
Current page
1
D File 021-584796

D filing

Filing date
21 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-91536

SCHEDULE 13D/A filing

Filing date
15 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
14 May 2026
Reporting date
12 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
14 May 2026
Reporting date
12 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-279718

424B5

Filing date
14 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-91536

SCHEDULE 13D/A filing

Filing date
16 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-91536

SCHEDULE 13G filing

Filing date
03 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-279718

424B5

Filing date
30 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-91536

SCHEDULE 13D/A filing

Filing date
23 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
13 Jan 2026
Reporting date
09 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
13 Jan 2026
Reporting date
09 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
13 Jan 2026
Reporting date
09 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
13 Jan 2026
Reporting date
09 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
13 Jan 2026
Reporting date
09 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
22 Dec 2025
Reporting date
18 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Dec 2025
Reporting date
18 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .